Popat S, Januszewski A, O'Brien M, Ahmad T, et al. Long term efficacy of first-line afatinib and the clinical utility of ctDNA monitoring in patients with suspected or confirmed EGFR mutant non-small cell lung cancer who were unsuitable for chemotherapy. Br J Cancer 2024 Dec 5. doi: 10.1038/s41416-024-02901.
PMID: 39639088